Jilin Jian Yisheng Pharmaceutical Co Ltd (002566) — Cash Flow-to-Debt Ratio
Jilin Jian Yisheng Pharmaceutical Co Ltd (002566) has a Cash Flow-to-Debt Ratio of 0.01x as of September 2025, meaning its operating cash flow of CN¥8.20 Million could theoretically repay 0% of its total liabilities (CN¥658.86 Million) in one year. See Jilin Jian Yisheng Pharmaceutical Co Ltd financial flexibility index to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Jilin Jian Yisheng Pharmaceutical Co Ltd Cash Flow-to-Debt Ratio (2006–2025)
Historical debt coverage capacity for Jilin Jian Yisheng Pharmaceutical Co Ltd across 20 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of Jilin Jian Yisheng Pharmaceutical Co Ltd.
Annual Cash Flow-to-Debt Ratio for Jilin Jian Yisheng Pharmaceutical Co Ltd (2006–2025)
Year-by-year debt coverage analysis for Jilin Jian Yisheng Pharmaceutical Co Ltd. Check 002566 cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.16x | CN¥98.74 Million | CN¥630.35 Million | ▲ +69.3% |
| 2024 | 0.09x | CN¥58.94 Million | CN¥637.22 Million | ▼ -68.4% |
| 2023 | 0.29x | CN¥209.13 Million | CN¥714.30 Million | ▲ +44.0% |
| 2022 | 0.20x | CN¥145.86 Million | CN¥717.18 Million | ▼ -37.0% |
| 2021 | 0.32x | CN¥215.10 Million | CN¥666.08 Million | ▲ +5.3% |
| 2020 | 0.31x | CN¥203.51 Million | CN¥663.86 Million | ▼ -36.2% |
| 2019 | 0.48x | CN¥210.87 Million | CN¥438.66 Million | ▲ +68.8% |
| 2018 | 0.28x | CN¥167.32 Million | CN¥587.49 Million | ▼ -20.4% |
| 2017 | 0.36x | CN¥270.65 Million | CN¥756.40 Million | ▲ +1875.9% |
| 2016 | -0.02x | CN¥-17.52 Million | CN¥869.67 Million | ▲ +94.5% |
| 2015 | -0.36x | CN¥-324.29 Million | CN¥888.65 Million | ▲ +54.4% |
| 2014 | -0.80x | CN¥-592.06 Million | CN¥739.24 Million | ▲ +9.1% |
| 2013 | -0.88x | CN¥-188.45 Million | CN¥213.79 Million | ▼ -181.2% |
| 2012 | 1.09x | CN¥79.08 Million | CN¥72.81 Million | ▲ +162.5% |
| 2011 | -1.74x | CN¥-112.12 Million | CN¥64.52 Million | ▼ -633.3% |
| 2010 | 0.33x | CN¥50.73 Million | CN¥155.66 Million | ▼ -61.8% |
| 2009 | 0.85x | CN¥125.25 Million | CN¥146.67 Million | ▲ +430.9% |
| 2008 | 0.16x | CN¥20.50 Million | CN¥127.43 Million | ▼ -73.5% |
| 2007 | 0.61x | CN¥82.66 Million | CN¥136.08 Million | ▲ +135.9% |
| 2006 | 0.26x | CN¥25.58 Million | CN¥99.35 Million | — |